HIGHFDA DRUG
Ascend Laboratories Recalls Amlodipine and Olmesartan Tablets Over Dissolution Issues
Ascend Laboratories recalled 8,568 bottles of Amlodipine and Olmesartan Medoxomil Tablets on July 21, 2025. The recall follows reports of low dissolution results, impacting the drug's effectiveness. Consumers should stop using the product and seek guidance immediately.
Amlodipine and Olmesartan Medoxomil
Failed Dissolution